Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Signs Letter of Intent with Large Multinational Pharmaceutical Company (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Nirvana Life Sciences Inc C.NIRV

Alternate Symbol(s):  NIRVF

Healthcare Biotechnology
Nirvana Life Sciences Inc. is a Canada-based company, which is engaged in the scientific research and development of therapeutic products derived from psychedelics. The Company is also focused on developing methodologies for standardized, quality-controlled extraction and purification of psychoactive compounds. The Company operates in a single reportable segment: research and development of... see more

Recent & Breaking News (CSE:NIRV)

CSE Bulletin: Reinstatement - Nirvana Life Sciences Inc. (NIRV)

Newsfile 2 days ago

Canadian Investment Regulatory Organization Trade Resumption - NIRV

Canada NewsWire 3 days ago

Canadian Investment Regulatory Organization Trading Halt - NIRV

Canada NewsWire September 5, 2024

ThreeD Capital Inc. Announces New YouTube Channel

GlobeNewswire March 25, 2024

Nirvana Life Sciences Inc. Announces Receipt of First North American Production of SOSA, a Patented, WHO Approved, Herbal Treatment for Opiate Addiction

Newsfile January 29, 2024

Nirvana Life Sciences Inc. Announces Acquisition of Licensed Distributor of a Patented, WHO Approved, Herbal Treatment for Opiate Addiction

Newsfile August 15, 2023

Nirvana Life Sciences Inc. Announces the Acquisition of Licensed Distributor of a Patented, WHO Approved, Herbal Treatment for Opiate Addiction

Newsfile June 7, 2023

Nirvana Life Sciences Inc. announces agreement to acquire the licensed distributor of a Patented, WHO approved, herbal treatment for opiate addiction

Canada NewsWire November 21, 2022

Nirvana (CSE:NIRV) appoints Sheldon Inwentash to the Board of Directors

Shoran Devi November 9, 2022

Nirvana Life Sciences Inc. Announces the Appointment of Sheldon Inwentash to the Board of Directors

Newsfile November 9, 2022

Nirvana Life Sciences Inc. Deuterates 7-Hydroxymitragynine to Create D7-h, an Analogue that May Improve Research and Formulations using Kratom Derivatives

Canada NewsWire September 22, 2022

Nirvana Life Sciences Inc. Announces a Method for Producing MDMA that Reduces Manufacturing Time by Two Thirds

Canada NewsWire September 7, 2022

Nirvana Life Sciences Inc. Announces License for a Delivery System for Psychedelic APIs

Canada NewsWire July 6, 2022

Nirvana Life Sciences Announces Approval To Build Vancouver Facility From Health Canada

Canada NewsWire June 28, 2022

Nirvana Life Sciences announces filing of Patent for novel isolation of 4-PO-Psilocin Prodrug Compound

Canada NewsWire June 23, 2022

Nirvana Life Sciences Announces Patent Filing

Canada NewsWire June 9, 2022

Nirvana (CSE:NIRV) sees positive psychedelic response against addiction relapse

Caroline Egan  June 2, 2022

IIROC Trade Resumption - NIRV

Canada NewsWire June 2, 2022

Nirvana Life Sciences Announces Positive Results for Addiction Relapse Prevention from Their Latest Pre-Clinical Psychedelic Drug Study

Canada NewsWire June 2, 2022

IIROC Trading Halt - NIRV

Canada NewsWire June 1, 2022